Compare Asahi Intecc Co., Ltd. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 11.11%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 98.37
3
Healthy long term growth as Net Sales has grown by an annual rate of 19.22%
4
With a growth in Net Profit of 17.9%, the company declared Outstanding results in Mar 26
Stock DNA
Pharmaceuticals & Biotechnology
JPY 1,000,833 Million (Mid Cap)
30.00
NA
0.00%
-0.32
19.06%
6.02
Revenue and Profits:
Net Sales:
37,100 Million
(Quarterly Results - Mar 2026)
Net Profit:
9,472 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.01%
0%
11.01%
6 Months
19.67%
0%
19.67%
1 Year
54.58%
0%
54.58%
2 Years
60.52%
0%
60.52%
3 Years
26.65%
0%
26.65%
4 Years
92.31%
0%
92.31%
5 Years
34.62%
0%
34.62%
Asahi Intecc Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
19.22%
EBIT Growth (5y)
30.15%
EBIT to Interest (avg)
98.37
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.73
Tax Ratio
38.95%
Dividend Payout Ratio
51.64%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.52%
ROE (avg)
11.11%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
5.39
EV to EBIT
21.72
EV to EBITDA
17.34
EV to Capital Employed
7.18
EV to Sales
6.20
PEG Ratio
0.48
Dividend Yield
NA
ROCE (Latest)
33.06%
ROE (Latest)
18.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
37,100.00
35,208.00
5.37%
Operating Profit (PBDIT) excl Other Income
15,229.00
13,631.00
11.72%
Interest
21.00
39.00
-46.15%
Exceptional Items
-940.00
0.00
Consolidate Net Profit
9,472.00
8,024.00
18.05%
Operating Profit Margin (Excl OI)
351.50%
322.00%
2.95%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 5.37% vs -2.36% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 18.05% vs -13.05% in Dec 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
120,025.00
107,547.00
11.60%
Operating Profit (PBDIT) excl Other Income
40,226.00
31,855.00
26.28%
Interest
214.00
226.00
-5.31%
Exceptional Items
-10,930.00
-199.00
-5,392.46%
Consolidate Net Profit
12,792.00
15,895.00
-19.52%
Operating Profit Margin (Excl OI)
250.60%
205.80%
4.48%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 11.60% vs 19.36% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is -19.52% vs 19.73% in Jun 2024
About Asahi Intecc Co., Ltd. 
Asahi Intecc Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






